Purchase Order W81K0021P0237
Award Date 10/1/21
Potential Completion Date 9/30/26
Potential Value $9.3K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Hood, TX 76544, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for molecular testing equipment, with a ceiling value of $247,811.23. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, on July 11, 2025. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type. The funding agency is the Defense Health Agency, a defense agency. The contract does not have a set-aside designation,...
- This federal contract award to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products, was issued by the Defense Health Agency. The $2,041,453.80 firm-fixed-price delivery order falls under Roche's General Services Administration (GSA) Schedule contract for critical analyzers and laboratory equipment. The contract provides clinical chemistry analyzers, reagents, and testing services to support the Department of Veterans Affairs, Department of...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $947,520.62, was awarded by the Medical Command within the U.S. Department of Defense on October 1, 2020 for a period ending on September 30, 2021. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation....
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for in vitro diagnostic testing services. The contract, which is a Blanket Purchase Agreement (BPA) call valued at $741,441.86, was awarded by the Defense Health Agency (DHA) with a completion date of September 5, 2020. The contract has a firm fixed price pricing type and does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the provision of COBAS assay medical laboratory equipment and supplies. The $68,149.02 firm-fixed-price contract was awarded on April 30, 2024 by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, and has an ultimate completion date of September 30, 2024. This contract is not a set-aside award. Roche Diagnostics, a foreign-owned for-profit manufacturer,...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $1,176,942.17, is a delivery order awarded by the Department of Veterans Affairs (VA) under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule contract. The award is for CHEMISTRY ANALYZERS CPRR, with an ultimate...
- The U.S. Defense Health Agency awarded a $1,691,672.05 firm-fixed-price definitive contract to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, for BRIDGE CHEMISTRY ANALYZER SERVICES and WAMC CHEMISTRY TESTING REAGENTS. The contract has an ultimate completion date of March 31, 2025. Roche Diagnostics is a global leader in diagnostic solutions and has multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs)...
- This federal contract award was made by the Office of the Director (a civilian agency) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $5,539.24 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call for chemicals under the General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III) and In Vitro...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,691,568.24 contract is a delivery order awarded on December 1, 2018, with a completion date of May 31, 2020. It is a firm-fixed-price...
- This federal contract award is for medical and surgical instruments, equipment, and supplies to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $4,710.08 firm fixed price Blanket Purchase Agreement (BPA) call was awarded by the Department of Defense's Defense Health Agency. The contract is not designated as a set-aside. Roche Diagnostics holds multiple...